Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
Raynaud disease
MeSH D011928 - raynaud disease
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D016491:
Peripheral vascular diseases
45 Companies
23 Drugs
$
Success rate
D000090122:
Livedoid vasculopathy
0 Companies
0 Drugs
Success rate
D011928:
Raynaud disease
31 Companies
5 Drugs
$
Success rate
D017675:
Crest syndrome
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
30
%
3/10
Phase 2
90
%
9/10
Phase 3
37
%
7/19
Approved:
4
Overall Success rate:
10%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Hydrochlorothiazide
Pfizer
Prazosin
,
TEMANOGREL
Bristol Myers Squibb
Hydrochlorothiazide
1
2
3
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use